A blocking peptide for transforming growth factor-β1 activation prevents hepatic fibrosis in vivo
- 1 November 2003
- journal article
- research article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 39 (5), 742-748
- https://doi.org/10.1016/s0168-8278(03)00377-5
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Regulation of Cell Growth by Redox-mediated Extracellular Proteolysis of Platelet-derived Growth Factor Receptor βPublished by Elsevier BV ,2001
- Inhibition of transforming growth factorβ prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated ratsHepatology, 2000
- The Activation Sequence of Thrombospondin-1 Interacts with the Latency-associated Peptide to Regulate Activation of Latent Transforming Growth Factor-βJournal of Biological Chemistry, 1999
- Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in ratsHepatology, 1999
- Thrombospondin-1 Is a Major Activator of TGF-β1 In VivoCell, 1998
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment StrategiesNew England Journal of Medicine, 1993
- Vitamin E dietary supplementation protects against carbon tetrachloride—induced chronic liver damage and cirrhosisHepatology, 1992
- A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the ratJournal of Hepatology, 1987
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitisHepatology, 1981